Singular Genomics Systems Inc
General ticker "OMIC" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $51.5M
Singular Genomics Systems Inc follows the US Stock Market performance with the rate: 17.1%.
Estimated limits based on current volatility of 1.9%: low 19.21$, high 19.94$
Factors to consider:
- Current price 14.6% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.70$, 16.88$]
- 2024-12-30 to 2025-12-30 estimated range: [2.61$, 9.12$]
Financial Metrics affecting the OMIC estimates:
- Negative: Non-GAAP EPS, $ of -39.34 <= 0.10
- Negative: Operating profit margin, % of -97.25 <= 1.03
- Negative: Operating cash flow per share per price, % of -71.31 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
- Positive: Interest expense per share, $ of 0.45 <= 0.74
Short-term OMIC quotes
Long-term OMIC plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.77MM | $2.91MM |
| Operating Expenses | $61.28MM | $94.25MM | $105.71MM |
| Operating Income | $-61.28MM | $-93.49MM | $-102.80MM |
| Non-Operating Income | $-37.49MM | $2.61MM | $7.98MM |
| Interest Expense | $0.85MM | $0.76MM | $1.10MM |
| R&D Expense | $32.66MM | $46.20MM | $47.76MM |
| Income(Loss) | $-98.77MM | $-90.88MM | $-94.82MM |
| Taxes | $0.00MM | $-2.61MM | $0.00MM |
| Profit(Loss) | $-98.77MM | $-88.27MM | $-94.82MM |
| Stockholders Equity | $336.17MM | $260.32MM | $179.01MM |
| Inventory | $3.01MM | $18.22MM | $13.57MM |
| Assets | $355.65MM | $327.98MM | $265.47MM |
| Operating Cash Flow | $-51.70MM | $-87.09MM | $-73.65MM |
| Capital expenditure | $4.86MM | $6.02MM | $0.97MM |
| Investing Cash Flow | $-130.86MM | $-39.57MM | $13.81MM |
| Financing Cash Flow | $372.13MM | $0.90MM | $0.70MM |
| Earnings Per Share* | $-40.95 | $-37.22 | $-39.08 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.